Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans
Authors:
- 1 August 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 3 (4) , 469-489
Abstract
The onset, intensity and duration of therapeutic response to a compound depend on the intrinsic pharmacological activity of the drug and pharmacokinetic factors related to its absorption, distribution, metabolism and elimination that are inherent to the biological system. The process of drug transfer from the site of administration to the systemic circulation and the interspecies factors that impact this process are the scope of this review. In general, the factors that influence oral drug bioavailability via absorption and metabolism can be divided into physicochemical/biopharmaceutical and physiological factors. Physicochemical and biopharmaceutical factors that influence permeability and solubility tend to be species independent. Although there are significant differences in the anatomy and physiology of the gastrointestinal tract, these are not associated with significant differences in the rate and extent of drug absorption between rats and humans. However, species differences in drug metabolism in rats and humans did result in significant species differences in bioavailability. Overall, this review provides a better understanding of the interplay between drug physicochemical/biopharmaceutical factors and species differences/similarities in the absorption and metabolism mechanisms that affect oral bioavailability in rats and humans. This will enable a more rational approach to perform projection of oral bioavailability in human using available rat in vivo data.Keywords
This publication has 152 references indexed in Scilit:
- Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancerEuropean Journal of Cancer, 2006
- CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish populationPharmacogenetics and Genomics, 2006
- Bioavailability and its assessmentJournal of Veterinary Pharmacology and Therapeutics, 2004
- Expression and inducibility of P450 enzymes during liver ontogenyMicroscopy Research and Technique, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Correlation of Drug Absorption with Molecular Surface PropertiesJournal of Pharmaceutical Sciences, 1996
- Repeated noninvasive measurement of gastrointestinal transit in ratsPhysiology & Behavior, 1989
- Rate-limiting barriers to intestinal drug absorption: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Pharmaceutical SaltsJournal of Pharmaceutical Sciences, 1977
- Unstirred layer thickness in perfused rat jejunum in vivoCellular and Molecular Life Sciences, 1976